In accordance with our consequences, Zienolddiny et al. (2004) confirmed that the IL-1β polymorphisms were markedly linked to lung cancer susceptibility in the Norwegian population, where the wild-type genotype IL-1β-511CC raised the odds of lung cancer (OR 2.5) compared with the less frequent genotype IL-1β-511TT. Here, IL1B is linked to lung cancer.